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ABSTRACT A mutagenic technique that "saturates" a
particular site in a protein with all possible amino acid
substitutions was used to study the role of residue 71 in
j3-lactamase (EC 3.5.2.6). Threonine is conserved at residue 71
in all class A fi-lactamases and is adjacent to the active site
Ser-70. All 19 mutants of the enzyme were characterized by the
penam and cephem antibiotic resistance they provided to
Escherichia coli LS1 cells. Surprisingly, cells producing any of
14 ofthe mutant j3-lactamases displayed appreciable resistance
to ampicillin; only cells with mutants having Tyr, Trp, Asp,
Lys, or Arg at residue 71 had no observable resistance to
ampicillin. However, the mutants are less stable to cellular
proteases than wild-type enzyme is. These results suggest that
Thr-71 is not essential for binding or catalysis but is important
for stability of the P-lactamase protein. An apparent change in
specificity indicates that residue 71 influences the region of the
protein that accommodates the side chain attached to the
,-lactam ring of the substrate.
The creation of mutant proteins with specific changes in
amino acid sequence by oligonucleotide-directed mutagene-
sis (1, 2) affords a general method for studies of the relation-
ship between structure and function. Recently, this approach
has been applied to several enzymes, including trypsin (3),
dihydrofolate reductase (4), aspartate carbamoyltransferase
(5), tyrosyl-tRNA synthetase (6, 7), triosephosphate isomer-
ase (8, 9), lysozyme (10), and 43-lactamase (11, 12). Insights
obtained from x-ray crystallography, computer modeling,
sequence homologies, and catalytic mechanism greatly assist
in predicting the consequences of a particular mutation on
protein function. However, even then a particular amino acid
substitution often causes a surprising change in activity; a
thorough study of the role of an important residue requires
substitution with all 19 other amino acids (site saturation).
Such a study was recently reported (13) for residue 12 in the
c-Ha-ras 1 gene; in this case the mutants were generated by
oligonucleotide-directed mutagenesis. All 19 amino acid
substitutions were also produced for residue 222 in subtilisin
by a technique similar to the one used here (14).
As an approach to structure-function studies, site satura-
tion becomes particularly attractive under two conditions: (1)
a procedure exists for efficiently generating the appropriate
mutants and (ii) the protein in question affects the phenotype
of cells such that one can easily screen for mutants that
perform a particular function. One can extend this approach
to the simultaneous saturation of two or more sites in a
protein to assess the effect of combinations of residues on
protein function or, perhaps, to create a novel activity.
Site saturation can be accomplished by introducing into the
gene at the codon for the residue of interest a mixture of
nucleotides: A, T, G, and C at the first two positions, G and
C at the third position. This mixture of oligonucleotides,
which codes for all 20 amino acids and the amber codon, can
be readily introduced into the gene as a "cassette" when
unique restriction sites are conveniently nearby. (If desired,
appropriate mixtures of oligonucleotides can be used to
encode a particular subset of amino acids.)
We have applied site saturation to the study of pBR322-
encoded ,3lactamase (EC 3.5.2.6). This is an RTEM-1
enzyme (12, 15) originally taken from R factor R1 (16, 17) that
catalyzes the hydrolysis of the f-lactam ring of penam and
cephem antibiotics (18). This activity confers resistance to
these antibiotics on cells that produce the enzyme and
thereby provides a convenient screening procedure to assess
the activities of mutants. The class A /3lactamases contain a
conserved triad (Ser-Thr-Xaa-Lys) (19) at the catalytic site;
this site includes Ser-70, whose hydroxyl group opens the
/3-lactam ring (20, 21). This study focuses on the conserved
Thr-71, whose role in the activity of 4-lactamase is unknown.
Restriction sites that flank the codon for Thr-71 were
introduced into pBR322 by oligonucleotide-directed muta-
genesis; an Ava I site at nucleotide 3972 and a Sca I site at
nucleotide 3937 were introduced. The DNA fragment be-
tween nucleotides 3972 and 3937 (Pro-62 to Val-74 in /3-
lactamase) was removed and replaced with a mixture of
synthetic double-stranded oligonucleotides that included 32
codons for residue 71 (codons for 20 amino acids and the
amber codon). The resulting mixture of plasmids was used to
transform Escherichia coli and the colonies were screened for
their sensitivity to penam and cephem antibiotics. Surpris-
ingly, cells containing any of 14 of the mutant /8-lactamases
displayed appreciable resistance to ampicillin; only cells
containing mutants with Tyr, Trp, Asp, Lys, or Arg at residue
71 had no observable resistance to ampicillin. The mutant
proteins show significantly increased sensitivity to proteol-
ysis.
MATERIALS AND METHODS
Restriction enzymes and the large (Klenow) fragment of
DNA polymerase I were purchased from Boehringer Mann-
heim. The T4 DNA ligase and T4 DNA kinase were obtained
from Bethesda Research Laboratories. All antibiotics were
from Sigma. The [a-32P]dTTP, 3000 ,Ci/mmol (1 Ci = 37
GBq), was purchased from Amersham and [y-32P]ATP was
from ICN.
Oligonucleotides were synthesized by using the phos-
phoramidite chemistry (22) on the Applied Biosystems (Fos-
ter City, CA) DNA synthesizer, model 380A. Mixed oligo-
nucleotides were produced by using an equimolar mixture of
the four nucleotide phosphoramidites or an equimolar mix-
ture of G and C nucleotide phosphoramidites in a normal
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coupling reaction. The oligonucleotides were purified by
preparative polyacrylamide gel electrophoresis.
Bacteriophage M13 mp 8 was grown in E. coli JM 103 (23)
in 2x YT medium and prepared according to standard
procedures (24). Plasmid pBR322 was grown in E. coli LS1
(25) in LB medium (28). Plasmid purification (26) and cell
transformations (27) were done by using standard proce-
dures. Selection involved growth in the presence of tetracy-
cline at 15 mg/liter or ampicillin at 100 mg/liter unless
otherwise stated. Numbering of pBR322 nucleotides is the
one commonly used (28).
Oligonucleotide-directed mutagenesis was carried out on
M13 mp 8 containing the 752-base-pair Pst I-EcoRI fragment
of pBR322. An Ava I site was introduced by changing T to C
at residue 3972 and a Sca I site was introduced by changing
A to T at residue 3939. Procedures used for the mutagenesis
are described elsewhere (29, 30). To remove the preexisting
Sca I site at 3846 on pBR322, the 61-base-pair segment
between HincII at 3907 and Sca I at 3846 was removed and
replaced by a 61-base-pair fragment that changed G to A at
3846.
To introduce the 20 amino acids at site 71, the following
mixture of oligonucleotides was used.
FAA1
5'-CC-GAG-GAA-CGT-TTT-CCA-ATG-ATG-AGC CCC TTC-AAA-GT
C-CTT-GCA-AAA-GGT-TAC-TAC-TCG GGG AAG-TTT-CA-5'
LTTJ
The asterisk indicates a silent mutation that removes a Dra
I restriction site at 3943 and also decreases the self-comple-
mentarity of 6 (and possibly as many as 10) bases near this
end of the individual strands. After purification, as described
above, the mixtures of oligonucleotides were individually
phosphorylated. They were then annealed by mixing 0.4
pmol/ILI of each strand and heating to 950C in 10 mM
MgCl2/50 mM Tris HCl, pH 8, followed by gradual cooling to
20°C over a 45-min period. The resulting mixture of double-
stranded oligonucleotides (0.4 pmol) was mixed with the Sal
I to Sca I fragment (0.04 pmol) and the Ava I to Sal I fragment
(0.04 pmol) from pBR322-CR7 and pBR322-XN1, respective-
ly (see Fig. 1). This mixture was ligated in 10 mM MgCl2/50
mM Tris HCl, pH 8/0.5 mM ATP/5 mM dithiothreitol con-
taining 10 units of T4 DNA ligase in a total volume of 50 ,ul
at 15°C for approximately 18 hr. The reaction mixture was
extracted with phenol and the DNA was precipitated by
addition of ethanol. The DNA was redissolved in 20 ,ul of 1
mM Tris HCl, pH 8/0.1 mM EDTA; an aliquot (5 ud) was
used for transformation of E. coli LS1 cells. After the
transformation, 1/10th of the cells were plated on tetracy-
cline, producing 423 colonies. From these, 108 individual
colonies were picked and inoculated onto tetracycline-con-
taining plates and were also tested for activity on the various
substrates of,-lactamase. Plasmids derived from these 108
colonies were sequenced.
For sequencing, the plasmids were digested with Ava I and
the resulting 2962-base-pair fragment was isolated from a
1.2% agarose gel by using DEAE-paper or the International
Biotechnologies (New Haven, CT) UEA electroelutor. The
fragment was labeled at T-3973 by using [a-32P]dTTP and the
Klenow fragment of DNA polymerase I. The labeled frag-
ments were sequenced by using standard techniques (31).
In L agar plates (28), an antibiotic concentration gradient
was generated by raising one end of a Petri dish (8.5-cm
diameter) 5 mm and pouring 15 ml of L agar containing an
appropriate concentration of antibiotic into the tilted dish.
These were allowed to dry overnight. The plates were then
placed on a flat horizontal surface and 15 ml of L agar was
poured on top; they were used immediately upon hardening.
An aliquot (50 ,1l) of a 1:105 dilution of a saturated culture
(approximately 2 x 109 cells per ml) was spread over half of
the plate. A standard mutant was plated on the other half;
standards used were as follows: for ampicillin and ben-
zylpenicillin at 37°C and for 6-aminopenicillanic acid at 30°C,
Thr-71 -+ Leu; for 6-aminopenicillanic acid at 37°C, Thr-71 -+
Cys; for ampicillin and benzylpenicillin at 30°C, Thr-71--* Glu.
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FIG. 1. Design of three-fragment ligation for inserting the mixture of oligonucleotides. bp, Base pair.
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Protein for electrophoretic transfer blots was prepared by
pelleting 1 x 109 E. coli LS1 cells from a late-logarithmic-
phase culture containing tetracycline at 15 mg/liter in LB
medium. These cells were resuspended in 100 ,l of 10%
(vol/vol) glycerol/5% (vol/vol) 2-mercaptoethanol/3% sodi-
um dodecyl sulfate/62.5 mM Tris HCl, pH 6.8, and incubated
10 min at 95°C. An aliquot (20 ,ul) was loaded onto a 15-cm
12% polyacrylamide gel with a 2-cm 4% stacking gel. After
electrophoresis, protein blots were prepared according to the
Bio-Rad procedure (32); the transfer was at 50 V for 5 hr.
Visualization was according to the Vectastain procedure (33)
using rabbit antibody to f-lactamase.
RESULTS
Introduction of the Ava I 3972 and Sca I 3937 sites and
removal of the Sca I 3845 site were verified by restriction
mapping of the plasmids. The absence of other changes in the
p-lactamase gene was verified by sequencing one of the
mutants from the Pst I site through the residues of the
structural gene encoding the protein N terminus.
After ligation of the mixture of oligonucleotides into the
plasmid, transformation of competent E. coli LS-1 cells gave
423 colonies that were resistant to tetracycline. From these
423 colonies, 108 were picked and inoculated onto tetracy-
cline plates and were also tested for resistance to ampicillin
(10, 50, 100, and 500 mg/liter), benzylpenicillin (100
mg/liter), 6-aminopenicillanic acid (10, 25, 50, and 100
mg/liter), cephalothin (25, 50, and 100 mg/liter), and
cephalexin (25 and 50 mg/liter). Ampicillin and cephalothin
plates were incubated at 30°C and 37°C; all others were
incubated only at 37°C. This phenotype screening indicated
that a change in antibiotic specificity and reduced stability,
particularly at 37°C, were characteristics of some of the
mutants.
Plasmids derived from 105 of the colonies were sequenced
fromAva I (3972) through Sca 1 (3937); Table 1 lists the codon
frequencies in this collection ofcolonies. The sequences were
matched to the phenotypes determined above. Mutants with
Tyr, Trp, Asp, Lys, or Arg at position 71 gave no resistance
to any ofthe five antibiotics. A mutant with Phe was resistant
to ampicillin at 100 mg/liter at 30°C but sensitive even to low
levels of ampicillin at 37°C. Mutants with Gly, Gln, or Glu
produced resistance up to 100 mg of ampicillin or benzyl-
penicillin per liter at 37°C. Mutants with Ala, Val, Leu, Ile,
Pro, His, Cys, Ser, Thr, or Asn gave resistance to ampicillin
at >500 mg/liter and benzylpenicillin at >100 mg/liter. Only
mutants with His, Cys, Ser, or Thr were resistant to 6-
aminopenicillanic acid at >100 mg/liter, those with Gly, Ala,
Val, Leu, Ile, Pro, Glu, or Asn were resistant to 25 mg/liter, and
those with Met or Gln (although resistant to ampicillin) showed
no resistance to 6-amino-penicillanic acid. Only the wild-type
enzyme (Thr-71) conferred resistance to cephalothin and
cephalexin at 37°C. A mutant, Thr-71 -* Ser, was resistant to
Table 1. Distribution of codons for residue 71
Codon No. Codon No. Codon No. Codon No.
AAC 2 CAC 3 GAC 2 TAC 8
AAG 6 CAG 3 GAG 3 TAG 2
ACC 4 CCC 1 GCC 5 TCC 5
ACG 2 CCG 2 GCG 4 TCG 3
AGC 3 CGC 0 GGC 2 TGC 4
AGG 4 CGG 2 GGG 1 TGG 5
ATC 6 CTC 1 GTC 0 TTC 1
ATG 7 CTG 2 GTG 2 TTG 6
In addition to these 101 point mutations, there were three deletions
at the Sca I site, six insertions at the Ava I site, one deletion at the
Ava I site, four insertions in the codon for residue 71, and one
insertion in the synthetic segment.
cephalothin at 50 mg/liter at 30°C, but none ofthe other mutants
grew in the presence of this antibiotic even at 30°C.
More accurate values for the level of antibiotic resistance
provided to cells by the mutant proteins were determined by
spreading cells onto an agar plate with a continuous concen-
tration gradient of antibiotic. The maximal concentration at
which colonies were established could then be observed.
These phenotypic characteristics are summarized in Table 2.
The values were independent of dilutions of cells higher by a
factor of 2 or lower by a factor of 10 than those used in the
experiments summarized in Table 2. Particularly noteworthy
are the resistances at 37°C of cells producing the mutants
Thr-71 -> Ile and Thr-71 -- His. In addition, the differences
in levels of resistance at 30°C versus those at 37°C are
especially dramatic.
Protein boiled in sodium dodecyl sulfate after extraction
from cultures of the various mutants grown at 30°C and 37°C
was electrophoresed in denaturing sodium dodecyl sulfate/
polyacrylamide gels and then transferred to nitrocellulose.
Fig. 2 shows antibody stains of these blots. Protein of the
same size as P3-lactamase is present for all mutants, but the
quantity varies substantially for different mutants; this vari-
ation is greatly reduced at 30°C. We believe that the protein
responsible for the band slightly above 3-lactamase is pre-
P-lactamase because it represents a protein of appropriate
size and because this band is absent for the Thr-71 -- amber
mutant. The blots suggest that the mutant proteins are
processed normally but that mature mutant proteins are
degraded, probably by E. coli proteases.
DISCUSSION
Importantly, for site-saturation studies, one should use
mixtures of synthetic oligonucleotides having all specified
codons at nearly equal frequencies; if codons for certain
amino acids are present at low frequencies, the correspond-
ing mutants will be underrepresented, difficult to find, and
Table 2. Maximal level of resistance of strains with mutations at
3-lactamase residue 71
Maximal antibiotic concentration (mg/liter)
at which colonies grew
Benzyl- 6-Amino-
Amino Ampicillin penicillin penicillin
acid 300C 370C 300C 370C 300C 370C
Gly >500 Trace >500 50 35 20
Ala >500 75 >500 100 Trace Trace
Val >500 150 >500 175 75 Trace
Leu >500 100 >500 125 80 Trace
Ile >500 >500 >500 >500 90 40
Met >500 125 >500 150 30 0
Pro >500 200 >500 350 50 40
Phe 60 0 0 0 0 0
Trp 0 0 0 0 0 0
Tyr 0 0 0 0 0 0
His >500 >500 >500 >500 >250 >250
Cys >500 >500 >500 >500 >250 100
Ser >500 >500 >500 >500 >250 >250
Thr >500 >500 >500 >500 >250 >250
Asn 270 Trace 210 Trace 55 Trace
Gln 130 20 70 Trace 55 0
Asp 0 0 0 0 0 0
Glu 200 Trace 70 Trace Trace Trace
Lys 0 0 0 0 0 0
Arg 0 0 0 0 0 0
Stop 0 0 0 0 0 0
A > indicates that this value was the highest level of antibiotic
tested.
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FIG. 2. Blots of (-lactamases with the 19 amino acid substitutions at residue 71. The blots were treated with rabbit anti-/-lactamase antibody
and visualized by using the horseradish peroxidase assay (see ref. 33).
may go untested in the phenotype screening, particularly
when multiple sites are involved. Nearly equimolar mixtures
of oligonucleotides can be obtained by careful synthesis (S.
Horvath, personal communication) and then used in cassette
mutagenesis to generate the various mutations with known
frequencies. In a Poisson distribution the probability of finding
a particular codon at least once among 101 colonies'is 96%. As
shown in Table 1, 94% (3Q/32) ofthe codons were observed one
or more times. The absence of two codons, therefore, was
probably the consequence of a small sample size.
In sequencing plasmids from 105 individual colonies we
found none in which the 35-base-pair segment contained
unexpected base substitutions. However, 14 frameshift mu-
tants resulting from single-base deletions or additions were
observed (see Table 2). The 9 additions and deletions at
restriction sites may occur during processing ofthe synthetic
fragment or during ligation; similar deletions have been
observed, for example, in ligation ofa synthetic fragment into
the Pst I site of the gene 'for subtilisin (14). The other 5
mutations that occur within the synthetic fragment probably
result from imperfections in the DNA synthesis. None of the
colonies containing plasmids with these frameshift mutations
show any resistance to penam or cephem antibiotics.
The antibiotic resistances of colonies containing the 19
mutant (3lactamases were initially determined by picking
colonies and patching them onto agar plates with various
levels of antibiotics. More accurate values were measured by
spreading mutant colonies onto agar plates having a linear
concentration gradient of antibiotics (see Table 2). This latter
method gives consistently lower values for antibiotic resist-
ance, as in this case individual cells must establish colonies,
whereas when colonies are picked and applied in patches
many cells are initially present at a single site, allowing them
to cooperate in inactivating sufficient antibiotic to allow
growth. Both sets of data are, however, useful, as colonies
with mutants having low lactamase activity would be classi-
fied as inactive if only plating were used. In Table 2, colonies
that grew when picked, but not when plated, are designated
as having trace activity.
The antibiotic resistance of colonies containing mutant
plasmids reflects many factors: plasmid replication, tran-
scription, stability and ease of translation of the mutant
mRNAs, stability of the pre-,/3lactamases in the cytoplasm,
possible differences in the rate of processing and secretion,
stability ofthe proteins in the periplasm, and, finally, intrinsic
enzymatic activity. With regard to the steps from transcrip-
tion to translation, the codon used for a given amino acid at
residue 71 did not alter observed antibiotic resistance; in all
cases, a given amino acid mutant confers the same level of
antibiotic resistance regardless ofwhich codon was used (see
Table 1).
Mutations may affect processing and secretion of proteins
(34) and thereby alter the relative concentrations of mutant
P-lactamases in the periplasm. Although mutants such as
Thr-71 -- Ser and Ser-70 Thr and the double mutant Ser-70
Thr, Thr-71 -- Ser seem to be processed and secreted
normally in Salmonella typhimurium (12), these mutations
are unlikely to affect these processes as drastically as
mutations such as Thr-71 -- Trp, Tyr, Lys; even in these
cases, however, abundant processed protein is apparent in
cells growing at 30'C (see Fig. 2).
Resistance to thermal denaturation and proteolysis can
greatly influence the in vivo concentration of mutant proteins
(12, 35). Analysis by protein blots (Fig. 2) for cell lysates of
colonies growing at 30'C and 370C show significant differ-
ences in the concentrations of mutants. A band representing
the precursor protein shows similar intensities for the mu-
tants and wild type; the presence of normal amounts of
precursor proteins suggests that processing and secretion
have not been drastically altered for the mutants. However,
the amounts of protein in the periplasm vary greatly for the
mutants as contrasted to wild type, particularly for cells
growing at 370C, indicating that the mutants are more
susceptible to proteolysis than the wild-type enzyme.
A surprising number of mutants with amino acid substitu-
tions at Thr-71 display lactamase activity; indeed, of the 19
substitutions at residue 71 only 5 (Trp, Tyr, Lys, Arg, or Asp)
give proteins that confer no observable resistance to ampicil-
lin or benzylpenicillin. Enzymes with Gin, Glu, Asn, or Phe
at residue 71 provide low-level resistance, but enzymes with
all other amino acids at this site have high activity toward
benzylpenicillin and ampicillin. Some preliminary conclu-
sions about structure-function relationships can be drawn
from these data. Mutants having amino acids with charged or
very large side chains at residue 71 have at best very low
activity, otherwise both polar and nonpolar side chains seem
compatible with appreciable activity. When 6-aminopenicil-
lanic acid is used to select for activity, mutants with amino
acids having nonpolar side chains show decreased activity,
whereas mutants with amino acids having polar side chains
retain activity toward this antibiotic. All mutants show a
dramatically decreased ability to confer resistance toward the
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cephem antibiotics cephalothin and cephalexin. At 300C,
wild-type P-lactamase (Thr-71) confers resistance to at least
100 mg/liter while the mutant Thr-71 -3 Ser confers resist-
ance only to low levels ofthe cephem antibiotics; at 370C only
wild-type enzyme provides observable resistance. Though
we have yet to characterize fully the inherent catalytic
activity of all the mutants at residue 71, some representative
data for benzylpenicillin as substrate are, respectively, kcat(sec1), Km (AuM), kcat/Km (M-1 sec'1), and relative values
for kcat/Km as follows: wild-type enzyme, 2000, 26, 7.7 x 107,
and 1; Thr-71 -- Ser, 300, 21, 1.6 x 107, and 0.21 (12); Thr-71
-- Ile, 1530, 350, 4.4 x 107, and 0.57 (Y. H. Chang and
J.H.R., unpublished results).
Because many mutants at residue 71, including those
having amino acids with polar and nonpolar side chains, show
appreciable activity toward penams, we conclude that Thr at
71 is not essential for binding and catalysis, though it may
perform some contributing role in these functions. However,
residue 71 does play a very important role in the structural
stability of the protein, as observed in the increased sensi-
tivity to proteolysis of all 19 mutants. The importance of
branching at the 8-carbon ofThr with a polar hydroxyl group
and nonpolar methyl group is demonstrated, for example, by
the increasing antibiotic resistance of cells growing at 37PC
provided by the series of enzymes with Gly < Ala < Leu <
Val. The increased thermal and proteolytic sensitivity rela-
tive to wild {ype ofthe mutant Thr-71 -) Ser (12), lacking only
the methyl group of Thr, further supports this view'.The
relatively high catalytic activities ofThr-71 -+ Cys and Thr-71
Ser demonstrate the importance of the polar group. The
reduced activity toward 6-aminopenicillanic acid of enzymes
having amino acids at residue 71 with nonpolar side chains
suggests that the side chains of residue 71 influence ,the
hydrophobic or hydrophilic characteristics of the pocket that
accommodates the substituent attached to the 83-lactam ring
of the substrates. This possibility is further emphasized by
the lower activity of enzymes with Glu or Gln at residue 71
toward benzylpenicillin (neutral, nonpolar substituent) than
toward ampicillin (positively charged, polar substituent).
All mutant enzymes confer on cells at best very low
resistance toward cephalothin and cephalexin; this likely
results from the inherently lower activity of f3-lactamase
against cephem antibiotics (36) and accords with results
observed for mutations in other regions of the enzyme (37).
This behavior also demonstrates the importance of the
conserved residues at the catalytic site in providing an
enzyme with high levels of catalytic activity and stability.
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